Hyperphosphatemia Treatment Market Size Worth USD 3.07 Billion by 2035 Driven by Rising Chronic Kidney Disease Cases

Source Summary

The Hyperphosphatemia Treatment Market is experiencing significant growth due to the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide. Hyperphosphatemia, characterized by elevated phosphate levels in the blood, is a common complication among patients with